Your browser doesn't support javascript.
loading
Hyperthermic intraoperative chemotherapy (HIOC) for Stage IVa thymic malignancy may improve 5-year disease-free survival.
Dolan, Daniel P; Polhemus, Emily; Lee, Daniel N; Mazzola, Emanuele; Jaklitsch, Michael T; Wee, Jon O; Bueno, Raphael; Swanson, Scott J; White, Abby.
Affiliation
  • Dolan DP; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Polhemus E; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Lee DN; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Mazzola E; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Jaklitsch MT; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Wee JO; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Bueno R; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Swanson SJ; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • White A; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
J Surg Oncol ; 127(4): 734-740, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36453475

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymoma / Thymus Neoplasms Type of study: Observational_studies Limits: Humans Language: En Journal: J Surg Oncol Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymoma / Thymus Neoplasms Type of study: Observational_studies Limits: Humans Language: En Journal: J Surg Oncol Year: 2023 Document type: Article Affiliation country: